DE69535975D1 - Glycosyltransferasen für die biosynthese von oligosacchariden und dafür kodierende gene - Google Patents
Glycosyltransferasen für die biosynthese von oligosacchariden und dafür kodierende geneInfo
- Publication number
- DE69535975D1 DE69535975D1 DE69535975T DE69535975T DE69535975D1 DE 69535975 D1 DE69535975 D1 DE 69535975D1 DE 69535975 T DE69535975 T DE 69535975T DE 69535975 T DE69535975 T DE 69535975T DE 69535975 D1 DE69535975 D1 DE 69535975D1
- Authority
- DE
- Germany
- Prior art keywords
- beta
- glycosyltransferases
- oligosaccharides
- mimic
- 4g1cnac
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/312,387 US5545553A (en) | 1994-09-26 | 1994-09-26 | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
PCT/US1995/012317 WO1996010086A1 (en) | 1994-09-26 | 1995-09-25 | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69535975D1 true DE69535975D1 (de) | 2009-08-13 |
Family
ID=23211210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69535975T Expired - Lifetime DE69535975D1 (de) | 1994-09-26 | 1995-09-25 | Glycosyltransferasen für die biosynthese von oligosacchariden und dafür kodierende gene |
Country Status (10)
Country | Link |
---|---|
US (9) | US5545553A (de) |
EP (2) | EP1568777B1 (de) |
JP (2) | JP3756182B2 (de) |
KR (1) | KR100465892B1 (de) |
AT (2) | ATE513916T1 (de) |
CA (2) | CA2200973A1 (de) |
DE (1) | DE69535975D1 (de) |
ES (1) | ES2371440T3 (de) |
MX (1) | MX9702351A (de) |
WO (1) | WO1996010086A1 (de) |
Families Citing this family (174)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09503905A (ja) * | 1993-07-15 | 1997-04-22 | ネオゼ ファーマシューティカルス | 糖組成物の合成方法 |
US6524812B1 (en) | 1993-10-07 | 2003-02-25 | Regents Of The University Of Minnesota | Genes encoding resistance to DNA alkylating agents |
US6495348B1 (en) | 1993-10-07 | 2002-12-17 | Regents Of The University Of Minnesota | Mitomycin biosynthetic gene cluster |
US5545553A (en) * | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
US6127153A (en) * | 1995-06-07 | 2000-10-03 | Neose Technologies, Inc. | Method of transferring at least two saccharide units with a polyglycosyltransferase, a polyglycosyltransferase and gene encoding a polyglycosyltransferase |
US6600029B1 (en) | 1995-12-19 | 2003-07-29 | Regents Of The University Of Minnesota | Metabolic engineering of polyhydroxyalkanoate monomer synthases |
US6096529A (en) | 1996-06-10 | 2000-08-01 | National Research Council Of Canada | Recombinant α-2,3-sialyltransferases and their uses |
AU718382B2 (en) * | 1996-11-08 | 2000-04-13 | Neose Technologies, Inc. | Improved expression vectors |
US5945314A (en) * | 1997-03-31 | 1999-08-31 | Abbott Laboratories | Process for synthesizing oligosaccharides |
US6045854A (en) * | 1997-03-31 | 2000-04-04 | Abbott Laboraties | Nutritional formulations containing oligosaccharides |
US5906982A (en) * | 1997-03-31 | 1999-05-25 | Abbott Laboratories | Nutritional formulations containing Lacto-N-neoTetraose |
US6075183A (en) * | 1997-04-11 | 2000-06-13 | Abbott Laboratories | Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants |
US7745694B1 (en) | 1997-04-11 | 2010-06-29 | Monsanto Technology Llc | Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
US5972664A (en) * | 1997-04-11 | 1999-10-26 | Abbott Laboratories | Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
US6051754A (en) * | 1997-04-11 | 2000-04-18 | Abbott Laboratories | Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants |
US5968809A (en) * | 1997-04-11 | 1999-10-19 | Abbot Laboratories | Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
US6096725A (en) * | 1997-07-02 | 2000-08-01 | Neose Technologies, Inc. | Methods of using αGal oligosaccharides as immune system targeting agents |
JPH11221079A (ja) | 1998-02-04 | 1999-08-17 | Kyowa Hakko Kogyo Co Ltd | 糖転移酵素および該酵素をコードするdna |
US6689604B1 (en) * | 1998-03-20 | 2004-02-10 | National Research Council Of Canada | Lipopolysaccharide α-2,3 sialyltransferase of Campylobacter jejuni and its uses |
EP1066388A2 (de) | 1998-03-25 | 2001-01-10 | GVS Gesellschaft für Erwerb und Verwertung Landwirtschaftlicher Pflanzensorten MBH | Prozessive glycosyltransferase |
US6459018B1 (en) | 1998-06-12 | 2002-10-01 | Monsanto Technology Llc | Polyunsaturated fatty acids in plants |
US6265202B1 (en) | 1998-06-26 | 2001-07-24 | Regents Of The University Of Minnesota | DNA encoding methymycin and pikromycin |
FR2780413B1 (fr) * | 1998-06-29 | 2003-03-21 | Centre Nat Rech Scient | Enzymes a activite alpha-galactosyltransferase de cellules d'insectes, et leurs utilisations |
US6897052B1 (en) | 1998-08-07 | 2005-05-24 | Glycodesign Holdings Ltd. | N-acetylglycosaminyl transferase genes |
WO2000012747A1 (en) * | 1998-08-31 | 2000-03-09 | Kurt Nilsson | Method for enzymatic synthesis of glycosides, disaccharides, and oligosaccharides |
US6403349B1 (en) | 1998-09-02 | 2002-06-11 | Abbott Laboratories | Elongase gene and uses thereof |
US20030163845A1 (en) * | 1998-09-02 | 2003-08-28 | Pradip Mukerji | Elongase genes and uses thereof |
MXPA01004982A (es) * | 1998-11-18 | 2004-09-27 | Neose Technologies Inc | Manufactura de bajo costo de oligosacaridos. |
US6689566B1 (en) * | 1999-01-14 | 2004-02-10 | Scantibodies Laboratory, Inc. | Methods, kits, and antibodies for detecting parathyroid hormone |
US7820393B2 (en) * | 1999-01-14 | 2010-10-26 | Scantibodies Laboratory, Inc. | Methods, kits and antibodies for detecting parathyroid hormone |
US6699705B2 (en) * | 1999-02-01 | 2004-03-02 | National Research Council Of Canada | Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics |
US6503744B1 (en) | 1999-02-01 | 2003-01-07 | National Research Council Of Canada | Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics |
EP1194567A1 (de) * | 1999-05-18 | 2002-04-10 | University Of Iowa Research Foundation | Produktion von komplexen kohlehydraten |
FR2796082B1 (fr) * | 1999-07-07 | 2003-06-27 | Centre Nat Rech Scient | Procede de production d'oligosaccharides |
US7070970B2 (en) | 1999-08-23 | 2006-07-04 | Abbott Laboratories | Elongase genes and uses thereof |
AUPQ275799A0 (en) * | 1999-09-10 | 1999-10-07 | Luminis Pty Limited | Recombinant bacterium expressing an oligosaccharide receptor mimic |
US6518037B2 (en) * | 1999-11-12 | 2003-02-11 | University Of Iowa Research Foundation | Two-component system that controls bacterial membrane synthesis |
AU781508B2 (en) | 2000-02-11 | 2005-05-26 | Glycozym Aps | UDP-galactose: beta-D-galactose-R 4-alpha-D-galactosyltransferase, alpha4Gal-T1 |
AU7684201A (en) | 2000-06-28 | 2002-01-08 | Glycofi Inc | Methods for producing modified glycoproteins |
US8697394B2 (en) * | 2000-06-28 | 2014-04-15 | Glycofi, Inc. | Production of modified glycoproteins having multiple antennary structures |
US7598055B2 (en) * | 2000-06-28 | 2009-10-06 | Glycofi, Inc. | N-acetylglucosaminyltransferase III expression in lower eukaryotes |
US7625756B2 (en) * | 2000-06-28 | 2009-12-01 | GycoFi, Inc. | Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
US7449308B2 (en) | 2000-06-28 | 2008-11-11 | Glycofi, Inc. | Combinatorial DNA library for producing modified N-glycans in lower eukaryotes |
US7863020B2 (en) | 2000-06-28 | 2011-01-04 | Glycofi, Inc. | Production of sialylated N-glycans in lower eukaryotes |
US20030194784A1 (en) * | 2001-04-17 | 2003-10-16 | Sherman David H. | DNA encoding methymycin and pikromycin |
WO2003016469A2 (en) | 2001-08-17 | 2003-02-27 | Neose Technologies, Inc. | Chemo-enzymatic synthesis of sialylated oligosaccharides |
US20030096281A1 (en) * | 2001-09-14 | 2003-05-22 | Ganesh Venkataraman | Methods of making glycomolecules with enhanced activities and uses thereof |
US8008252B2 (en) * | 2001-10-10 | 2011-08-30 | Novo Nordisk A/S | Factor VII: remodeling and glycoconjugation of Factor VII |
EP2279755B1 (de) * | 2001-10-10 | 2014-02-26 | ratiopharm GmbH | Neumodulierung und Glykokonjugation von Fibroblasten-Wachstumsfaktor (FGF) |
US7297511B2 (en) * | 2001-10-10 | 2007-11-20 | Neose Technologies, Inc. | Interferon alpha: remodeling and glycoconjugation of interferon alpha |
WO2004099231A2 (en) | 2003-04-09 | 2004-11-18 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
US7265085B2 (en) * | 2001-10-10 | 2007-09-04 | Neose Technologies, Inc. | Glycoconjugation methods and proteins/peptides produced by the methods |
US7179617B2 (en) | 2001-10-10 | 2007-02-20 | Neose Technologies, Inc. | Factor IX: remolding and glycoconjugation of Factor IX |
US7265084B2 (en) * | 2001-10-10 | 2007-09-04 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
US7173003B2 (en) | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
US7226903B2 (en) * | 2001-10-10 | 2007-06-05 | Neose Technologies, Inc. | Interferon beta: remodeling and glycoconjugation of interferon beta |
US7795210B2 (en) | 2001-10-10 | 2010-09-14 | Novo Nordisk A/S | Protein remodeling methods and proteins/peptides produced by the methods |
US7696163B2 (en) | 2001-10-10 | 2010-04-13 | Novo Nordisk A/S | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US7399613B2 (en) * | 2001-10-10 | 2008-07-15 | Neose Technologies, Inc. | Sialic acid nucleotide sugars |
US7157277B2 (en) | 2001-11-28 | 2007-01-02 | Neose Technologies, Inc. | Factor VIII remodeling and glycoconjugation of Factor VIII |
US7125843B2 (en) * | 2001-10-19 | 2006-10-24 | Neose Technologies, Inc. | Glycoconjugates including more than one peptide |
US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US7439043B2 (en) * | 2001-10-10 | 2008-10-21 | Neose Technologies, Inc. | Galactosyl nucleotide sugars |
EP2305314B1 (de) | 2001-10-10 | 2015-12-23 | ratiopharm GmbH | Neumodulierung und Glykokonjugation von Antikörpern |
US7473680B2 (en) * | 2001-11-28 | 2009-01-06 | Neose Technologies, Inc. | Remodeling and glycoconjugation of peptides |
MXPA04012496A (es) | 2002-06-21 | 2005-09-12 | Novo Nordisk Healthcare Ag | Glicoformos del factor vii pegilados. |
KR101239242B1 (ko) | 2002-08-02 | 2013-03-11 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 항원 조합물을 포함하는 나이세리아 백신 조성물 |
US7332299B2 (en) * | 2003-02-20 | 2008-02-19 | Glycofi, Inc. | Endomannosidases in the modification of glycoproteins in eukaryotes |
EP1603932B1 (de) | 2003-03-06 | 2012-10-03 | Seneb Biosciences Inc. | Verfahren und zusammensetzungen für die enzymatische synthese von gangliosiden |
BRPI0408358A (pt) | 2003-03-14 | 2006-03-21 | Neose Technologies Inc | polìmeros hidrossolúveis ramificados e seus conjugados |
US8791070B2 (en) | 2003-04-09 | 2014-07-29 | Novo Nordisk A/S | Glycopegylated factor IX |
EP1613261A4 (de) * | 2003-04-09 | 2011-01-26 | Novo Nordisk As | Intrazelluläre bildung von peptidkonjugaten |
AU2004240553A1 (en) | 2003-05-09 | 2004-12-02 | Neose Technologies, Inc. | Compositions and methods for the preparation of human growth hormone glycosylation mutants |
WO2005012484A2 (en) | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Antibody-toxin conjugates |
ES2323644T3 (es) | 2003-08-21 | 2009-07-22 | Monsanto Technology Llc | Desaturasas de acidos grasos procedentes de primula. |
US20070254834A1 (en) * | 2003-11-24 | 2007-11-01 | Defrees Shawn | Glycopegylated Erythropoietin |
US20080305992A1 (en) * | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
US7842661B2 (en) | 2003-11-24 | 2010-11-30 | Novo Nordisk A/S | Glycopegylated erythropoietin formulations |
US8633157B2 (en) | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
US20060040856A1 (en) * | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
US20080318850A1 (en) * | 2003-12-03 | 2008-12-25 | Neose Technologies, Inc. | Glycopegylated Factor Ix |
US7956032B2 (en) * | 2003-12-03 | 2011-06-07 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
EP1694274B1 (de) * | 2003-12-03 | 2013-04-24 | BioGeneriX AG | Glykopegylierter Granulocyten-Kolonie-stimulierender Faktor |
EP1689348B1 (de) | 2003-12-05 | 2013-05-15 | Children's Hospital Medical Center | Oligosaccharid-Zusammensetzungen und ihre Verwendung bei der Behandlung von Infektionen |
CA2552892C (en) | 2004-01-08 | 2014-08-05 | Neose Technologies, Inc. | O-linked glycosylation of peptides |
JP4892358B2 (ja) | 2004-02-04 | 2012-03-07 | ノヴォ ノルディスク アー/エス | 哺乳動物グリコシルトランスフェラーゼをリフォールディングする方法 |
ES2541537T3 (es) | 2004-04-16 | 2015-07-21 | Monsanto Technology, Llc | Expresión de desaturasas de ácido graso en maíz |
DE602005019038D1 (de) | 2004-05-04 | 2010-03-11 | Novo Nordisk Healthcare Ag | O-verknüpfte glykoformen von faktor vii und verfahren zu deren herstellung |
WO2006010143A2 (en) | 2004-07-13 | 2006-01-26 | Neose Technologies, Inc. | Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] |
WO2006020372A2 (en) * | 2004-07-23 | 2006-02-23 | Neose Technologies, Inc. | Enzymatic modification of glycopeptides |
US8268967B2 (en) | 2004-09-10 | 2012-09-18 | Novo Nordisk A/S | Glycopegylated interferon α |
US20080108557A1 (en) * | 2004-09-29 | 2008-05-08 | Novo Nordisk Healthcare A/G | Modified Proteins |
EP1814573B1 (de) | 2004-10-29 | 2016-03-09 | ratiopharm GmbH | Remodellierung und glykopegylierung von fibroblasten-wachstumsfaktor (fgf) |
JP2008526864A (ja) * | 2005-01-06 | 2008-07-24 | ネオス テクノロジーズ インコーポレイテッド | 糖断片を用いる糖結合 |
ES2449195T3 (es) | 2005-01-10 | 2014-03-18 | Ratiopharm Gmbh | Factor estimulante de colonias de granulocitos glicopegilado |
WO2006105426A2 (en) * | 2005-03-30 | 2006-10-05 | Neose Technologies, Inc. | Manufacturing process for the production of peptides grown in insect cell lines |
EP1871795A4 (de) | 2005-04-08 | 2010-03-31 | Biogenerix Ag | Zusammensetzungen und verfahren zur herstellung von glycosylierungsmutanten eines proteaseresistenten menschlichen wachstumshormons |
US20080255026A1 (en) * | 2005-05-25 | 2008-10-16 | Glycopegylated Factor 1X | Glycopegylated Factor Ix |
US20110003744A1 (en) * | 2005-05-25 | 2011-01-06 | Novo Nordisk A/S | Glycopegylated Erythropoietin Formulations |
US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
AU2006280932A1 (en) * | 2005-08-19 | 2007-02-22 | Novo Nordisk A/S | Glycopegylated factor VII and factor Vila |
US20090048440A1 (en) * | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes |
JP5275983B2 (ja) | 2006-06-12 | 2013-08-28 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
BRPI0714390B1 (pt) | 2006-07-19 | 2018-05-15 | Monsanto Technology Llc | Polinucleotídeo, construção de dna, célula hospedeira fúngica ou bacteriana, processo para produção de alimento ou de produto alimentício e composição para alimento ou produto alimentício |
CN101516388B (zh) * | 2006-07-21 | 2012-10-31 | 诺和诺德公司 | 通过o-联糖基化序列的肽的糖基化 |
WO2008057683A2 (en) * | 2006-10-03 | 2008-05-15 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates |
DK2068907T3 (en) * | 2006-10-04 | 2018-01-15 | Novo Nordisk As | GLYCEROL BOND PEGYLED SUGAR AND GLYCOPE Peptides |
US20080207487A1 (en) * | 2006-11-02 | 2008-08-28 | Neose Technologies, Inc. | Manufacturing process for the production of polypeptides expressed in insect cell-lines |
KR20100016160A (ko) | 2007-04-03 | 2010-02-12 | 바이오제너릭스 에이지 | 글리코페길화 g―csf를 이용하는 치료 방법 |
US20090053167A1 (en) * | 2007-05-14 | 2009-02-26 | Neose Technologies, Inc. | C-, S- and N-glycosylation of peptides |
JP2010531135A (ja) * | 2007-06-04 | 2010-09-24 | ノボ ノルディスク アクティーゼルスカブ | N−アセチルグルコサミニルトランスフェラーゼを使用したo結合型グリコシル化 |
WO2008154639A2 (en) | 2007-06-12 | 2008-12-18 | Neose Technologies, Inc. | Improved process for the production of nucleotide sugars |
US7968811B2 (en) * | 2007-06-29 | 2011-06-28 | Harley-Davidson Motor Company Group, Inc. | Integrated ignition and key switch |
US8207112B2 (en) | 2007-08-29 | 2012-06-26 | Biogenerix Ag | Liquid formulation of G-CSF conjugate |
CN102037004A (zh) * | 2008-01-08 | 2011-04-27 | 生物种属学股份公司 | 使用寡糖基转移酶的多肽的糖缀合 |
ES2476690T3 (es) | 2008-02-27 | 2014-07-15 | Novo Nordisk A/S | Moléculas conjugadas del Factor VIII |
NZ596099A (en) | 2009-04-13 | 2013-11-29 | Childrens Hosp Medical Center | Milk oligosaccharide compositions and use thereof in treating infection in animals |
ES2651067T3 (es) | 2009-07-06 | 2018-01-24 | Children's Hospital Medical Center | Inhibición de la inflamación con oligosacáridos de la leche |
MX2012011648A (es) | 2010-04-07 | 2012-11-29 | Momenta Pharmaceuticals Inc | Glicanos de alta manosa. |
EP2465509A1 (de) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Oligosaccharid Zusammensetzung zur Behandlung von akuten Atemwegsinfektionen |
EP2454948A1 (de) | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharidmischung und Lebensmittel mit dieser Mischung, insbesondere Säuglingsnahrung |
EP2465507A1 (de) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Oligosaccharid Zusammensetzung zur Behandlung von Hautkrankheiten |
EP2465508A1 (de) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Zusammensetzung mit hydrolysierten Proteinen und Oligosacchariden zur Behandlung von Hautkrankheiten |
JP5860480B2 (ja) | 2011-01-11 | 2016-02-16 | キャプシュゲル・ベルジウム・エヌ・ヴィ | プルランを含む新しい硬カプセル |
US9170249B2 (en) | 2011-03-12 | 2015-10-27 | Momenta Pharmaceuticals, Inc. | N-acetylhexosamine-containing N-glycans in glycoprotein products |
BR112014008944B1 (pt) | 2011-10-18 | 2020-09-15 | Société des Produits Nestlé S.A. | Composição nutricional simbiótica compreendendo lc-pufa, probiótico e mistura de oligossacarídeos para crescimento cerebral e/ou desenvolvimento cognitivo e/ou psicomotor |
PL2768312T3 (pl) | 2011-10-18 | 2016-06-30 | Nestec Sa | Kompozycja do stosowania dla wspomagania zdrowego rozwoju oraz/albo w zapobieganiu oraz/albo w leczeniu chorób kości |
EP2768311B1 (de) | 2011-10-18 | 2018-02-21 | Nestec S.A. | Zusammensetzung zur verwendung bei der förderung der intestinalen angiogenese und der nährstoffabsorption und der enteralen ernährungstoleranz und/oder bei der prävention und/oder behandlung von darmentzündung und/oder bei der erholung nach darmverletzungen und -operationen |
BR112014007829A2 (pt) | 2011-10-18 | 2017-04-18 | Nestec Sa | composição para uso na promoção de absorção de magnésio e/ou retenção de magnésio |
PT2768314E (pt) | 2011-10-18 | 2016-02-17 | Nestec Sa | Composição para utilização no aumento de sensibilidade à insulina e/ou redução da resistência à insulina |
EP2856159A4 (de) | 2012-06-01 | 2016-04-13 | Momenta Pharmaceuticals Inc | Verfahren im zusammenhang mit denosumab |
TWI563092B (en) * | 2012-08-20 | 2016-12-21 | Academia Sinica | Large scale enzymatic synthesis of oligosaccharides |
US10450361B2 (en) | 2013-03-15 | 2019-10-22 | Momenta Pharmaceuticals, Inc. | Methods related to CTLA4-Fc fusion proteins |
US10464996B2 (en) | 2013-05-13 | 2019-11-05 | Momenta Pharmaceuticals, Inc. | Methods for the treatment of neurodegeneration |
EP3058084A4 (de) | 2013-10-16 | 2017-07-05 | Momenta Pharmaceuticals, Inc. | Sialylierte glycoproteine |
EP3111942B1 (de) | 2013-11-15 | 2021-01-06 | Société des Produits Nestlé S.A. | Zusammensetzungen zur verwendung in der prävention oder behandlung von atemwegsinfektionen bei gefährdeten kleinkindern oder kindern |
WO2015071401A1 (en) | 2013-11-15 | 2015-05-21 | Nestec S.A. | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section |
EP3071208B1 (de) | 2013-11-15 | 2021-08-11 | Société des Produits Nestlé S.A. | Zusammensetzungen zur verwendung bei der vorbeugung oder behandlung von nekrotisierende enterokolitis bei säuglingen und kleinkindern |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
AU2016227595B2 (en) | 2015-03-05 | 2020-08-27 | Société des Produits Nestlé S.A. | Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children |
WO2016139333A1 (en) | 2015-03-05 | 2016-09-09 | Nestec S.A. | Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children |
RU2731154C2 (ru) | 2015-03-05 | 2020-08-31 | Сосьете Де Продюи Нестле С.А. | Композиция для применения в улучшении консистенции или частоты стула у младенцев или детей младшего возраста |
AU2017307455B2 (en) | 2016-08-04 | 2023-07-06 | Société des Produits Nestlé S.A. | Nutritional compositions with 2FL and LNnT for use in preventing and/or treating non-rotavirus diarrhea by acting on the gut microbiota dysbiosis |
MX2019001906A (es) | 2016-09-07 | 2019-07-15 | Soc Des Produits Nestle S A Star | Composiciones nutricionales para lactantes y/o niños pequeños que comprenden oligosacaridos. |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
CN110678555B (zh) | 2017-04-14 | 2023-10-13 | 比利时胶囊公司 | 制作普鲁兰的方法 |
US11576870B2 (en) | 2017-04-14 | 2023-02-14 | Capsugel Belgium Nv | Pullulan capsules |
EP4382108A2 (de) | 2017-05-09 | 2024-06-12 | Société des Produits Nestlé S.A. | Synergistische herstellung von butyrat im zusammenhang mit der komplexität einer hmos-mischung zur verwendung bei säuglingen oder kleinkindern für gesundheitszwecke |
EP3629770A1 (de) | 2017-05-24 | 2020-04-08 | Société des Produits Nestlé S.A. | Zusammensetzung mit oligofructose (of) zur verwendung bei der verbesserung des kurzzeitgedächtnisses und anderer kognitiver vorteile |
CN110799045A (zh) | 2017-05-24 | 2020-02-14 | 雀巢产品有限公司 | 用于改善短期记忆和其他认知益处的包含人乳低聚糖(hmo)的组合物 |
US11260067B2 (en) | 2017-05-24 | 2022-03-01 | Societe Des Produits Nestle S.A. | Methods and compositions for decreasing concentrations of detrimental proteolytic metabolites, treating health disorders, and/or promoting health benefits in infants or young children |
CN111479573B (zh) | 2017-12-21 | 2024-05-24 | 雀巢产品有限公司 | 用于促进肠道肌肉生长和发育以及相关联的肠道能动性的组合物 |
WO2019122178A1 (en) | 2017-12-21 | 2019-06-27 | Societe Des Produits Nestle S.A. | Compositions comprising at least on n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children |
US11357785B2 (en) | 2017-12-22 | 2022-06-14 | Societe Des Produits Nestle S.A. | Compositions for use in the reduction of nociception in infants and young children |
BR112020023102A2 (pt) | 2018-06-25 | 2021-02-02 | Société des Produits Nestlé S.A. | uso de oligossacarídeos de leite humano, e composição que compreende os mesmos |
MX2020012783A (es) | 2018-06-25 | 2021-01-20 | Nestle Sa | Composicion que comprende oligosacaridos de la leche humana para uso en la mejora, refuerzo, promocion o modulacion de una funcion serotonergica en el sistema nervioso central. |
EP3650044A1 (de) * | 2018-11-06 | 2020-05-13 | ETH Zürich | Anti-glykan-impfstoffe |
MX2021005668A (es) | 2018-11-30 | 2021-06-15 | Nestle Sa | Composicion nutricional infantil para usar en el mejoramiento de la maduracion pancreatica y la biosintesis de insulina. |
DE202019005475U1 (de) | 2018-12-21 | 2020-09-23 | Société des Produits Nestlé S.A. | Eine Nahrungsmittelzusammensetzung umfassend 2'-Fucosyllactose zur Verbesserung der gastrointestinalen Barriere |
WO2020126587A1 (en) | 2018-12-21 | 2020-06-25 | Societe Des Produits Nestle S.A. | A NUTRITIONAL COMPOSITION COMPRISING METABOLITES OF HMOs TO IMPROVE THE GASTROINTESTINAL BARRIER |
CN113163833A (zh) | 2018-12-21 | 2021-07-23 | 雀巢产品有限公司 | 包含6′sl和lnt的组合以改善胃肠屏障功能的营养组合物 |
CN113518622A (zh) | 2019-03-05 | 2021-10-19 | 雀巢产品有限公司 | 用于增强执行功能的营养组合物 |
AU2020309556A1 (en) * | 2019-07-08 | 2022-03-03 | Crapaud Bio, Inc. | Methods of making and using lipooligosaccharide compositions and vaccines |
JP2022551829A (ja) | 2019-10-17 | 2022-12-14 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 高度加水分解された乳児用フォーミュラ |
EP4044829A1 (de) | 2019-10-17 | 2022-08-24 | Société des Produits Nestlé S.A. | Säuglingsnahrung |
EP4072319A1 (de) | 2019-12-11 | 2022-10-19 | Société des Produits Nestlé S.A. | Zusammensetzungen zur verwendung bei der verringerung der nozizeption und anderer gesundheitlicher vorteile bei säuglingen und kleinkindern |
EP4084628A1 (de) | 2019-12-30 | 2022-11-09 | Société des Produits Nestlé S.A. | Säuglingsnahrung |
JP2023545766A (ja) | 2020-10-16 | 2023-10-31 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 乳児又は低年齢の小児用フォーミュラ |
EP4228436A1 (de) | 2020-10-16 | 2023-08-23 | Société des Produits Nestlé S.A. | Ernährungszusammensetzung mit menschlichen milcholigosacchariden |
JP2023547175A (ja) | 2020-11-10 | 2023-11-09 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 栄養組成物 |
WO2022129556A1 (en) | 2020-12-18 | 2022-06-23 | Société des Produits Nestlé S.A. | Compositions for use in promoting accelerated butyrate production in young children |
CN117915787A (zh) | 2021-06-29 | 2024-04-19 | 博德研究所有限公司 | 长双歧杆菌过渡型微生物、其组合物及其用途 |
WO2023237305A1 (en) | 2022-06-09 | 2023-12-14 | Société des Produits Nestlé S.A. | Nutritional composition comprising gos and hmos |
Family Cites Families (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1479268A (en) * | 1973-07-05 | 1977-07-13 | Beecham Group Ltd | Pharmaceutical compositions |
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
CH596313A5 (de) * | 1975-05-30 | 1978-03-15 | Battelle Memorial Institute | |
US4385260A (en) * | 1975-09-09 | 1983-05-24 | Beckman Instruments, Inc. | Bargraph display |
US4414147A (en) * | 1981-04-17 | 1983-11-08 | Massachusetts Institute Of Technology | Methods of decreasing the hydrophobicity of fibroblast and other interferons |
JPS57206622A (en) * | 1981-06-10 | 1982-12-18 | Ajinomoto Co Inc | Blood substitute |
US4496689A (en) * | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US4565653A (en) * | 1984-03-30 | 1986-01-21 | Pfizer Inc. | Acyltripeptide immunostimulants |
US4879236A (en) * | 1984-05-16 | 1989-11-07 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
JPS6238172A (ja) * | 1985-08-12 | 1987-02-19 | 株式会社 高研 | 抗血栓性医用材料の製造方法 |
US4767702A (en) * | 1986-02-06 | 1988-08-30 | Cohenford Menashi A | Paper strip assay for neisseria species |
US4925796A (en) * | 1986-03-07 | 1990-05-15 | Massachusetts Institute Of Technology | Method for enhancing glycoprotein stability |
US5153265A (en) * | 1988-01-20 | 1992-10-06 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
GB8810808D0 (en) * | 1988-05-06 | 1988-06-08 | Wellcome Found | Vectors |
US5169933A (en) * | 1988-08-15 | 1992-12-08 | Neorx Corporation | Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
US5874261A (en) * | 1988-09-02 | 1999-02-23 | The Trustees Of The University Of Pennsylvania | Method for the purification of glycosyltransferases |
US6166183A (en) * | 1992-11-30 | 2000-12-26 | Kirin-Amgen, Inc. | Chemically-modified G-CSF |
US5194376A (en) * | 1989-02-28 | 1993-03-16 | University Of Ottawa | Baculovirus expression system capable of producing foreign gene proteins at high levels |
US5182107A (en) * | 1989-09-07 | 1993-01-26 | Alkermes, Inc. | Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates |
US5154924A (en) * | 1989-09-07 | 1992-10-13 | Alkermes, Inc. | Transferrin receptor specific antibody-neuropharmaceutical agent conjugates |
US5977307A (en) * | 1989-09-07 | 1999-11-02 | Alkermes, Inc. | Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
US5527527A (en) * | 1989-09-07 | 1996-06-18 | Alkermes, Inc. | Transferrin receptor specific antibody-neuropharmaceutical agent conjugates |
US5672683A (en) * | 1989-09-07 | 1997-09-30 | Alkermes, Inc. | Transferrin neuropharmaceutical agent fusion protein |
DE4009630C2 (de) * | 1990-03-26 | 1995-09-28 | Reinhard Prof Dr Dr Brossmer | CMP-aktivierte fluoreszierende Sialinsäuren sowie Verfahren zu ihrer Herstellung |
US5180674A (en) * | 1990-04-16 | 1993-01-19 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
CU22302A1 (es) * | 1990-09-07 | 1995-01-31 | Cigb | Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales |
US5352670A (en) * | 1991-06-10 | 1994-10-04 | Alberta Research Council | Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides |
KR950014915B1 (ko) * | 1991-06-19 | 1995-12-18 | 주식회사녹십자 | 탈시알로당단백-포함화합물 |
FI100051B (fi) * | 1992-02-18 | 1997-09-15 | Favorit Oy | Kompostori |
US6037452A (en) * | 1992-04-10 | 2000-03-14 | Alpha Therapeutic Corporation | Poly(alkylene oxide)-Factor VIII or Factor IX conjugate |
US5614184A (en) * | 1992-07-28 | 1997-03-25 | New England Deaconess Hospital | Recombinant human erythropoietin mutants and therapeutic methods employing them |
JP3979678B2 (ja) * | 1992-08-24 | 2007-09-19 | サントリー株式会社 | 新規糖転移酵素及びそれをコードする遺伝子並びに該酵素の製造方法 |
US5374541A (en) * | 1993-05-04 | 1994-12-20 | The Scripps Research Institute | Combined use of β-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides |
EP0726318A1 (de) * | 1993-05-14 | 1996-08-14 | The Upjohn Company | Akzeptorpolypeptid für N-Acetylgalaktosaminyltransferase |
US5621039A (en) * | 1993-06-08 | 1997-04-15 | Hallahan; Terrence W. | Factor IX- polymeric conjugates |
US5443953A (en) * | 1993-12-08 | 1995-08-22 | Immunomedics, Inc. | Preparation and use of immunoconjugates |
US5369017A (en) * | 1994-02-04 | 1994-11-29 | The Scripps Research Institute | Process for solid phase glycopeptide synthesis |
US5492841A (en) * | 1994-02-18 | 1996-02-20 | E. I. Du Pont De Nemours And Company | Quaternary ammonium immunogenic conjugates and immunoassay reagents |
US5432059A (en) * | 1994-04-01 | 1995-07-11 | Specialty Laboratories, Inc. | Assay for glycosylation deficiency disorders |
US5646113A (en) * | 1994-04-07 | 1997-07-08 | Genentech, Inc. | Treatment of partial growth hormone insensitivity syndrome |
US5545553A (en) * | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
US5834251A (en) * | 1994-12-30 | 1998-11-10 | Alko Group Ltd. | Methods of modifying carbohydrate moieties |
US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
US6030815A (en) * | 1995-04-11 | 2000-02-29 | Neose Technologies, Inc. | Enzymatic synthesis of oligosaccharides |
US5728554A (en) * | 1995-04-11 | 1998-03-17 | Cytel Corporation | Enzymatic synthesis of glycosidic linkages |
US5922577A (en) * | 1995-04-11 | 1999-07-13 | Cytel Corporation | Enzymatic synthesis of glycosidic linkages |
US5876980A (en) * | 1995-04-11 | 1999-03-02 | Cytel Corporation | Enzymatic synthesis of oligosaccharides |
US6015555A (en) * | 1995-05-19 | 2000-01-18 | Alkermes, Inc. | Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates |
DK1568772T3 (da) * | 1995-09-21 | 2010-10-18 | Genentech Inc | Varianter af humant væksthormon |
US5716812A (en) * | 1995-12-12 | 1998-02-10 | The University Of British Columbia | Methods and compositions for synthesis of oligosaccharides, and the products formed thereby |
IL130823A (en) * | 1996-10-15 | 2005-12-18 | Elan Pharm Inc | Peptide-lipid conjugates, liposomes drug delivery |
US5945314A (en) * | 1997-03-31 | 1999-08-31 | Abbott Laboratories | Process for synthesizing oligosaccharides |
US6183738B1 (en) * | 1997-05-12 | 2001-02-06 | Phoenix Pharamacologics, Inc. | Modified arginine deiminase |
US20030027257A1 (en) * | 1997-08-21 | 2003-02-06 | University Technologies International, Inc. | Sequences for improving the efficiency of secretion of non-secreted protein from mammalian and insect cells |
AU744303B2 (en) * | 1997-12-01 | 2002-02-21 | Neose Technologies, Inc. | Enzymatic synthesis of gangliosides |
EP0924298A1 (de) * | 1997-12-18 | 1999-06-23 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Proteinexpression in Baculovirus-vektor Expressionsystemen |
PT1061954E (pt) * | 1998-03-12 | 2004-10-29 | Nektar Therapeutics Al Corp | Derivados de poli(etileno glicol) com grupos reactivos proximos |
DE19852729A1 (de) * | 1998-11-16 | 2000-05-18 | Werner Reutter | Rekombinante Glycoproteine, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und ihre Verwendung |
US6261805B1 (en) * | 1999-07-15 | 2001-07-17 | Boyce Thompson Institute For Plant Research, Inc. | Sialyiation of N-linked glycoproteins in the baculovirus expression vector system |
US6642038B1 (en) * | 1999-09-14 | 2003-11-04 | Genzyme Glycobiology Research Institute, Inc. | GlcNAc phosphotransferase of the lysosomal targeting pathway |
EP1525889A1 (de) * | 2000-05-15 | 2005-04-27 | F. Hoffmann-La Roche Ag | Flüssige Arzneizubereitung enthaltend ein Erythropoietinderivat |
AU7684201A (en) * | 2000-06-28 | 2002-01-08 | Glycofi Inc | Methods for producing modified glycoproteins |
US6531121B2 (en) * | 2000-12-29 | 2003-03-11 | The Kenneth S. Warren Institute, Inc. | Protection and enhancement of erythropoietin-responsive cells, tissues and organs |
US20020168323A1 (en) * | 2001-05-11 | 2002-11-14 | Igor Gonda | Optimization of the molecular properties and formulation of proteins delivered by inhalation |
US7795210B2 (en) * | 2001-10-10 | 2010-09-14 | Novo Nordisk A/S | Protein remodeling methods and proteins/peptides produced by the methods |
US7125843B2 (en) * | 2001-10-19 | 2006-10-24 | Neose Technologies, Inc. | Glycoconjugates including more than one peptide |
EP2279755B1 (de) * | 2001-10-10 | 2014-02-26 | ratiopharm GmbH | Neumodulierung und Glykokonjugation von Fibroblasten-Wachstumsfaktor (FGF) |
US7214660B2 (en) * | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US7696163B2 (en) * | 2001-10-10 | 2010-04-13 | Novo Nordisk A/S | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
CA2468230A1 (en) * | 2001-11-28 | 2003-06-05 | Neose Technologies, Inc. | Glycopeptide remodeling using amidases |
KR20050083677A (ko) * | 2002-09-05 | 2005-08-26 | 더 제너럴 하스피탈 코포레이션 | 변형 아시알로 인터페론 및 그의 용도 |
US20070254834A1 (en) * | 2003-11-24 | 2007-11-01 | Defrees Shawn | Glycopegylated Erythropoietin |
US8633157B2 (en) * | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
EP1694351A2 (de) * | 2003-12-03 | 2006-08-30 | Neose Technologies, Inc. | Glycopegyliertes follikel-stimulierendes hormon |
CA2552892C (en) * | 2004-01-08 | 2014-08-05 | Neose Technologies, Inc. | O-linked glycosylation of peptides |
US20060024286A1 (en) * | 2004-08-02 | 2006-02-02 | Paul Glidden | Variants of tRNA synthetase fragments and uses thereof |
US20070105755A1 (en) * | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
-
1994
- 1994-09-26 US US08/312,387 patent/US5545553A/en not_active Expired - Lifetime
-
1995
- 1995-09-25 DE DE69535975T patent/DE69535975D1/de not_active Expired - Lifetime
- 1995-09-25 MX MX9702351A patent/MX9702351A/es not_active IP Right Cessation
- 1995-09-25 CA CA002200973A patent/CA2200973A1/en not_active Abandoned
- 1995-09-25 CA CA2502785A patent/CA2502785C/en not_active Expired - Lifetime
- 1995-09-25 ES ES05076067T patent/ES2371440T3/es not_active Expired - Lifetime
- 1995-09-25 AT AT05076067T patent/ATE513916T1/de not_active IP Right Cessation
- 1995-09-25 EP EP05076067A patent/EP1568777B1/de not_active Expired - Lifetime
- 1995-09-25 WO PCT/US1995/012317 patent/WO1996010086A1/en active IP Right Grant
- 1995-09-25 AT AT95934548T patent/ATE435290T1/de not_active IP Right Cessation
- 1995-09-25 JP JP51197896A patent/JP3756182B2/ja not_active Expired - Fee Related
- 1995-09-25 EP EP95934548A patent/EP0784688B1/de not_active Expired - Lifetime
- 1995-09-25 KR KR1019970701978A patent/KR100465892B1/ko not_active IP Right Cessation
-
1996
- 1996-07-18 US US08/683,426 patent/US5705367A/en not_active Expired - Lifetime
- 1996-07-18 US US08/683,458 patent/US5798233A/en not_active Expired - Fee Related
-
1997
- 1997-06-18 US US08/878,360 patent/US5945322A/en not_active Expired - Lifetime
-
1999
- 1999-06-15 US US09/333,412 patent/US6342382B1/en not_active Expired - Lifetime
-
2001
- 2001-12-03 US US10/007,267 patent/US6780624B2/en not_active Expired - Fee Related
-
2003
- 2003-09-02 US US10/654,528 patent/US20040043464A1/en not_active Abandoned
-
2005
- 2005-04-08 US US11/102,497 patent/US20050271690A1/en not_active Abandoned
- 2005-06-29 JP JP2005189933A patent/JP3976765B2/ja not_active Expired - Lifetime
-
2010
- 2010-06-14 US US12/815,272 patent/US8268596B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3756182B2 (ja) | 2006-03-15 |
AU3685695A (en) | 1996-04-19 |
ES2371440T3 (es) | 2012-01-02 |
ATE435290T1 (de) | 2009-07-15 |
EP0784688B1 (de) | 2009-07-01 |
US20100316675A1 (en) | 2010-12-16 |
US20020127682A1 (en) | 2002-09-12 |
CA2502785C (en) | 2011-05-17 |
ATE513916T1 (de) | 2011-07-15 |
US20040043464A1 (en) | 2004-03-04 |
EP0784688A1 (de) | 1997-07-23 |
KR100465892B1 (ko) | 2005-07-18 |
US5945322A (en) | 1999-08-31 |
AU714684B2 (en) | 2000-01-06 |
US6342382B1 (en) | 2002-01-29 |
WO1996010086A1 (en) | 1996-04-04 |
US20050271690A1 (en) | 2005-12-08 |
JPH10509301A (ja) | 1998-09-14 |
US5798233A (en) | 1998-08-25 |
JP3976765B2 (ja) | 2007-09-19 |
EP1568777A1 (de) | 2005-08-31 |
MX9702351A (es) | 1997-10-31 |
US8268596B2 (en) | 2012-09-18 |
US6780624B2 (en) | 2004-08-24 |
KR970706400A (ko) | 1997-11-03 |
CA2502785A1 (en) | 1996-04-04 |
JP2005296022A (ja) | 2005-10-27 |
US5545553A (en) | 1996-08-13 |
US5705367A (en) | 1998-01-06 |
CA2200973A1 (en) | 1996-04-04 |
EP1568777B1 (de) | 2011-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69535975D1 (de) | Glycosyltransferasen für die biosynthese von oligosacchariden und dafür kodierende gene | |
Na et al. | Recent progress in synthesis of carbohydrates with sugar nucleotide-dependent glycosyltransferases | |
Li et al. | Strategies for chemoenzymatic synthesis of carbohydrates | |
DE60028541D1 (de) | Campylobacter glycolsyltransferasen zur verwendung bei der biosynthese von gangliosiden und ganglioside imitatoren | |
US5246840A (en) | Method for synthesis of oligosaccharides | |
Palcic | Glycosyltransferases as biocatalysts | |
McArthur et al. | Glycosyltransferase engineering for carbohydrate synthesis | |
US5374541A (en) | Combined use of β-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides | |
Kapitonov et al. | Conserved domains of glycosyltransferases | |
Zervosen et al. | A novel three-enzyme reaction cycle for the synthesis of N-acetyllactosamine with in situ regeneration of uridine 5 ‘-diphosphate glucose and uridine 5 ‘-diphosphate galactose | |
Audry et al. | Current trends in the structure–activity relationships of sialyltransferases | |
Seibel et al. | Glycosylation with activated sugars using glycosyltransferases and transglycosidases | |
US5409817A (en) | Use of trans-sialidase and sialyltransferase for synthesis of sialylα2→3βgalactosides | |
MXPA00005376A (es) | Sintesis enzimatica de gangliosidos. | |
MXPA03008565A (es) | Glicosiltransferasas de campylobacter para la biosintesis de gangliosidos y mimeticos de gangliocido. | |
DE69732628D1 (de) | Beta 1-4 n-acetylglucosaminyltransferase sowie das für diese kodierende gen | |
EP1632566A3 (de) | Varianten der Cyclomaltodextrin-Glucanotransferase | |
Pallister et al. | Enzyme promiscuity of carbohydrate active enzymes and their applications in biocatalysis | |
Namdjou et al. | A β‐1, 4‐Galactosyltransferase from Helicobacter pylori is an Efficient and Versatile Biocatalyst Displaying a Novel Activity for Thioglycoside Synthesis | |
Homann et al. | Towards tailor-made oligosaccharides—chemo-enzymatic approaches by enzyme and substrate engineering | |
HUP0104121A2 (hu) | Fruktozil-transzferáz aktivitású enzimeket kódoló nukleinsav-molekulák és alkalmazásuk | |
Halcomb et al. | Synthesis of oligosaccharides, glycopeptides, and glycolipids | |
Bårström et al. | New derivatives of reducing oligosaccharides and their use in enzymatic reactions: efficient synthesis of sialyl Lewis a and sialyl dimeric Lewis x glycoconjugates | |
Sunthankar et al. | Synthesis of 5-azido-UDP-N-acetylhexosamine photoaffinity analogs and radiolabeled UDP-N-acetylhexosamines | |
Tseng et al. | Exploring regioselective fucosylation catalyzed by bacterial glycosyltransferases through substrate promiscuity and acceptor-mediated glycosylation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |